Uncovering the Truth: Pomerantz Law Firm Investigates Claims Against Brainstorm Cell Therapeutics Inc. on Behalf of Shareholders
Breaking News: Pomerantz LLP Investigating Claims Against Brainstorm Cell Therapeutics Inc. New York, Nov. 28, 2023 /PRNewswire/ — Pomerantz LLP is currently investigating claims on behalf of investors of Brainstorm Cell Therapeutics Inc. (“Brainstorm” or the “Company”) (NASDAQ: BCLI). If you are one of the investors, please contact Robert S. Willoughby at [email protected] or 888-476-6529,…